06/01/2026
Currently Enrolling! A phase III clinical trial to assess the effect of an investigational medicine on major adverse cardiovascular events in patients with established Atherosclerotic Cardiovascular Disease (ASCVD) or at high risk for a first ASCVD event is now enrolling at all 3 locations!
For our Bowling Green office, call 270-904-4334. Or register online for more information at:
https://qualmedicaresearch.com/dyslipidemia-ascvd-and-elevated-ldl-trial/